Superficial fungal infections: tinea, pityriasis versicolor, candidiasis and complete management
On this page
01
Overview
Superficial mycoses are infections of keratinised tissues — skin, hair and nails — or the moist mucosal folds. They range from cosmetically disturbing but mild colour changes to inflammatory dermatophyte infection, scalp disease with permanent alopecia, and extensive disease in diabetes or immunosuppression. The key clinical skill is to identify the anatomic site, distinguish dermatophytes from yeast and non-fungal mimics, and choose topical or systemic therapy based on depth and extent.
Do not treat every itchy rash as “ringworm”: confirm the morphology, site and likely organism.
02
Learning objectives
- Classify dermatophyte, yeast and other superficial infections.
- Explain transmission, keratin digestion and inflammatory patterns.
- Recognise tinea of the body, groin, foot, scalp and nail, pityriasis versicolor, piedra, tinea nigra and cutaneous candidiasis.
- Perform and interpret KOH microscopy, culture, Wood-lamp examination and dermoscopy where available.
- Select topical versus oral treatment with correct doses, and prevent recurrence, reinfection and steroid-modified tinea.
03
Classification
Scroll the table sideways on a smaller screen.
| Group | Examples | Typical tissue |
|---|---|---|
| Dermatophytes | Trichophyton, Microsporum, Epidermophyton | Stratum corneum, hair and nails; named tinea or ringworm |
| Yeasts | Candida, Malassezia | Moist folds, mucosa, skin surface and sebaceous areas |
| Other superficial fungi | Hortaea werneckii, Piedraia, Trichosporon | Palms/soles or hair shafts, usually limited disease |
04
Transmission and risk factors
Dermatophytes spread by direct contact, infected humans or animals, contaminated floors, combs, clothing and towels. Warm humid climates, occlusive footwear, communal bathing, contact sports, obesity, diabetes, peripheral vascular disease, HIV, corticosteroids and immunosuppressive medicines increase risk. Auto-inoculation from the feet to groin, nails or hands is common. Chronic steroid-containing combination creams suppress inflammation while allowing fungal growth, producing tinea incognito — a widespread, atypical, minimally scaly eruption that no longer looks like classic ringworm.
05
Pathophysiology
Dermatophytes digest keratin using proteases and remain mainly in the stratum corneum. The advancing edge of active infection contains more fungus and inflammation, producing an annular plaque with central clearing. Host cell-mediated immunity determines inflammation: a strong response causes vesicles and pustules, while impaired immunity allows extensive or atypical lesions. Malassezia alters melanocyte function and produces azelaic-acid-like metabolites, leading to hypo- or hyperpigmented macules. Candida overgrowth follows moisture, maceration and altered local immunity.
06
Clinical syndromes
Tinea corporis
Annular scaly plaques with a raised active border, central clearing and peripheral vesicles. Lesions may be multiple or confluent. Examine feet, nails and household contacts as reservoirs.
Tinea cruris
Itchy erythematous plaques begin in the groin and spread onto the upper thigh, usually sparing the scrotum. Bilateral scrotal involvement or satellite pustules suggests candidiasis instead.
Tinea pedis
- Interdigital maceration and fissuring (“athlete’s foot”).
- Moccasin-type diffuse scale on soles and lateral feet.
- Inflammatory vesiculobullous type after an immune response.
- Complications: bacterial cellulitis through fissures and onychomycosis.
Tinea capitis
Common in children: scaling, broken hairs, black dots, alopecia, kerion (boggy inflammatory plaque) or favus. Kerion can scar and cause permanent hair loss; treat systemically and assess contacts.
Tinea unguium / onychomycosis
Thickened, discoloured, brittle or separated nails. Distal-lateral, white superficial and proximal patterns occur. Psoriasis, trauma and lichen planus mimic fungal nails; confirm before prolonged oral therapy.
Pityriasis versicolor
Fine-scaling hypo- or hyperpigmented macules on trunk, neck and upper arms, more obvious after sun exposure. KOH shows short curved hyphae and round yeast (“spaghetti and meatballs”). Pigment normalisation may take months after cure.
Candidal intertrigo
Beefy-red macerated plaques in folds with satellite papules and pustules. Risk factors include obesity, diabetes, antibiotics, pregnancy and immunosuppression.
Piedra and tinea nigra
White (soft) or black (hard) nodules attached to hair shafts occur in piedra. Tinea nigra produces a slowly enlarging brown-black palm or sole macule without inflammation and can mimic melanoma.
07
History and examination
Ask about duration, itch or pain, spread, contacts, animal exposure, footwear, shared showers, prior steroid creams, diabetes, HIV, medicines and previous treatment. Examine the entire skin, scalp, nails, interdigital spaces, groin, mouth and mucosal sites; a local lesion may coexist with an untreated reservoir elsewhere. Look for bacterial infection, lymphadenopathy, fever, kerion and scarring.
08
Diagnosis
Scroll the table sideways on a smaller screen.
| Test | Use | Limitations |
|---|---|---|
| KOH preparation | Skin scale, nail scrapings or hair; demonstrates branching septate hyphae or yeast | Operator-dependent; negative test does not exclude disease if sampling is poor |
| Fungal culture | Species identification, scalp/nail/refractory infection | Slow; prior antifungal use can cause false negatives |
| Wood lamp | Some Microsporum hair infections fluoresce green; erythrasma fluoresces coral-pink | Many dermatophytes do not fluoresce; not a rule-out test |
| Nail clipping / PAS | Confirms onychomycosis before oral therapy | Requires laboratory processing; nail dystrophy has many mimics |
Sample the active scaly edge after cleaning off creams. For scalp, pluck broken hairs and scrape scale. In steroid-modified lesions stop unnecessary steroid and sample multiple sites.
09
Differential diagnosis
Atopic or contact dermatitis, psoriasis, seborrhoeic dermatitis, pityriasis rosea, erythrasma, intertrigo, bacterial impetigo, scabies, lichen planus, vitiligo, post-inflammatory pigment change and cutaneous lymphoma. A changing pigmented acral lesion requires melanoma assessment, not empirical antifungal therapy alone.
10
Management
General measures
- Keep folds and feet dry; change socks and underwear daily.
- Do not share towels, combs, hats, shoes or nail instruments.
- Treat infected pets or close contacts when indicated.
- Control diabetes, reduce occlusion and stop non-prescribed steroid combinations.
Topical versus oral therapy
Limited tinea corporis, cruris and pedis respond to topical allylamine or azole creams used for the full recommended duration, extending slightly beyond clinical clearing (see the drug table). Tinea capitis, extensive disease, nail infection, recurrent disease and treatment failure require oral therapy — topical agents do not penetrate hair shafts or nails adequately. Kerion, severe vesicular tinea or bacterial superinfection needs prompt systemic antifungal treatment and sometimes antibacterial therapy; avoid steroid monotherapy.
11
Drug summary table
Scroll the table sideways on a smaller screen.
| Drug | Dose | Indication | Adverse effects / cautions |
|---|---|---|---|
| Clotrimazole 1–2% cream | Apply BD for 2–4 weeks, continuing 1–2 weeks after the lesion clears | Tinea corporis, cruris, limited pedis; candidal intertrigo | Local irritation; cheaper courses fail when stopped at first symptom relief — finish the course |
| Terbinafine 1% cream | Apply once daily for 1–2 weeks | Tinea corporis, cruris, pedis (allylamine — fungicidal, shorter courses than azoles) | Local irritation; avoid broken skin; oral form has separate cautions below |
| Terbinafine (oral) | 250 mg once daily: skin infection 2–4 weeks; tinea capitis 4–6 weeks; nails 6–12 weeks (fingernails shorter); children weight-banded (e.g., 62.5–250 mg daily by weight) | Tinea capitis (first-line for Trichophyton), onychomycosis, extensive or failed topical disease | Hepatotoxicity — ask about liver disease, consider baseline LFTs for courses over 6 weeks; taste disturbance; rare severe skin reactions; reduces effect of codeine; check interactions |
| Griseofulvin (oral) | Adults 500 mg–1 g once daily; children 10–20 mg/kg/day; tinea capitis usually 6–8 weeks (microsize); take with a fatty meal to aid absorption | Tinea capitis (especially Microsporum), tinea corporis in children | Headache, nausea, photosensitivity; avoid in pregnancy and severe liver disease; reduces reliability of combined oral contraceptives during and for a month after treatment; potentiates warfarin and alcohol (disulfiram-like reaction) |
| Itraconazole (oral) | Pityriasis versicolor: 200 mg once daily for 7 days; onychomycosis: 200 mg BD for 1 week, repeated monthly for 2–3 pulses (fingernails) or 3–4 pulses (toenails); capsules with food, solution fasting | Pityriasis versicolor, onychomycosis, refractory dermatophytosis | Hepatotoxicity; contraindicated in heart failure; many interactions (statins, warfarin, some antiretrovirals, antacids reduce absorption); take capsules with food |
| Fluconazole (oral) | Pityriasis versicolor: 150–300 mg once weekly for 2–4 weeks; extensive cutaneous candidiasis: 150 mg once weekly for 2–4 weeks | Pityriasis versicolor, extensive candidal skin disease when topical care is impractical | Interactions (warfarin, sulfonylureas, QT-prolonging drugs); avoid in pregnancy; see the candidiasis note for full cautions |
| Selenium sulfide 2.5% lotion/shampoo | Apply to affected trunk areas, leave 10 minutes, rinse; repeat weekly for 2–4 weeks; ketoconazole 2% shampoo as an alternative short-contact wash | Pityriasis versicolor (topical therapy and to reduce relapse) | Local irritation, dryness; avoid eyes; pigment takes months to normalise after cure |
| Nystatin cream | Apply BD–TDS to folds for 2 weeks | Candidal intertrigo (first-line topical) | Minimal absorption, very safe; keep the fold dry alongside treatment |
12
Special syndromes
- Tinea capitis: topical therapy alone is inadequate. Examine household members, avoid sharing combs, and combine oral treatment with antifungal shampoo to reduce spore shedding.
- Onychomycosis: confirm fungus (clipping or PAS) before months of systemic therapy; assess liver function and interactions.
- Diabetes/HIV: search for extensive disease, bacterial cellulitis and recurrent infection; optimise the underlying condition.
- Pregnancy/children: prefer topical agents; avoid oral terbinafine and itraconazole in pregnancy; weight-band paediatric doses.
13
Complications and referral
- Permanent scarring alopecia after untreated kerion or favus.
- Bacterial cellulitis or lymphangitis through fissured feet.
- Disseminated or atypical disease in immunosuppression.
- Drug hepatotoxicity and interactions from prolonged oral treatment.
- Refer uncertain pigmented lesions, severe scalp inflammation, nail disease requiring systemic therapy, recurrent disease and immunocompromised patients.
14
Clinical scenario
Scenario 1 — The boy with the boggy scalp swelling
A 6-year-old boy is brought with a 3-week history of a painful, boggy, pus-draining swelling on the scalp with hair loss and tender neck lymph nodes. His mother has been applying a “stop-itch” combination cream from a shop, with brief improvement each time. This is a kerion — a severe inflammatory form of tinea capitis — and every day of steroid-containing cream deepens the risk of permanent scarring alopecia. Stop the combination cream, take plucked hairs and scale for KOH and culture, and start oral antifungal therapy (terbinafine weight-banded or griseofulvin 10–20 mg/kg/day for 6–8 weeks); add an antifungal shampoo for the household. Reassure the mother that the hair regrows if treatment starts before scarring sets in, screen siblings, and refer if a fluctuant abscess needs drainage or the diagnosis is uncertain.
Scenario 2 — “The ringworm that keeps coming back”
A 34-year-old market vendor has used an antifungal-steroid combination cream on recurrent groin and foot rashes for two years. The rash now covers both thighs and the soles with little scale — tinea incognito from chronic topical steroid. Explain that the steroid hides and feeds the problem: stop the combination cream (expect a temporary flare of redness), confirm with a KOH scraping from the active edge, and treat with terbinafine 250 mg daily for 2–4 weeks plus hygiene measures — dry folds, daily sock changes, no shared towels. If nail involvement is found, extend the course (6–12 weeks) and check baseline liver function. Screen for diabetes, which commonly hides behind recurrent tinea.
15
Exam pearls
- Sample the active edge, not the quiet centre.
- Tinea cruris usually spares the scrotum; candidiasis produces satellite pustules.
- Kerion is inflammatory tinea capitis and can scar.
- Pigment can remain abnormal for months after pityriasis versicolor is cured.
- Never give a steroid–antifungal combination without a clear indication and follow-up.
16
Key points
17
References
- SlideShare: Superficial fungal infections (Library reference.)
- SlideShare: Superficial fungal infections — clinical review (Library reference.)
- Current Uganda Clinical Guidelines and dermatology/antifungal treatment guidance (Library reference.)
- British National Formulary (BNF) — antifungal doses (Library reference.)
18
Further reading
For deeper study, compare this lesson with current guidance and standard references from recognised medical and public-health organisations.
For education only. Apply current Uganda Clinical Guidelines, local protocols and specialist advice in clinical practice.